X T L Biopharmaceuticals reported $371K in Cash and Equivalent for its fiscal quarter ending in December of 2024.


Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.09M 592K Dec/2024
Bioline Rx USD 7.19M 1.85M Jun/2025
Teva Pharmaceutical Industries USD 2.16B 464M Jun/2025
X T L Biopharmaceuticals USD 371K 449K Dec/2024